Fig. 4
From: Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
Correlation of DDC and DDDs of EGFR TKIs in Nanjing from 2010 to 2019. A Correlation between total DDC and DDDs of Gefitinib in Nanjing from 2010 to 2019; (B) Correlation between total DDC and DDDs of Erlotinib in Nanjing from 2010 to 2019; (C) Correlation between total DDC and DDDs of Icotinib in Nanjing from 2010 to 2019; (D) Correlation between self-paid DDC and DDDs of Gefitinib in Nanjing from 2010 to 2019; (E) Correlation between self-paid DDC and DDDs of Erlotinib in Nanjing from 2010 to 2019; (F) Correlation between self-paid DDC and DDDs of Icotinib in Nanjing from 2010 to 2019. DDC, defined daily dose; DDDs, defined daily doses